A total of 211 cases of monkeypox have been reported in France this year. The French Public Health Agency issued a communique on the 11th, saying that 211 cases of monkeypox have been reported in France this year, including 2 new cases in the past two weeks. The communique said that these monkeypox patients are all adults, including 203 males and 8 females. According to reports, after viral gene sequencing, 168 cases were infected with monkeypox virus II, of which 61 cases were further diagnosed as infected monkeypox virus IIb. (Xinhua News Agency)Treasury futures rose by 0.30%, the 30-year main contract rose by 0.30%, and the 30-year main contract rose by 0.30%, a record high. The 10-year main contract rose by 0.12%, the 5-year main contract rose by 0.05% and the 2-year main contract rose by 0.02%.In the inter-bank market, the yield of the active 10-year treasury bond "24 Treasury Bond with Interest 11" dropped by 1bp to 1.815%. Wind data shows that compared with yield to maturity, a Chinese bond with the same term, it hit a record low.
The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9BP upside down from the current 1-year treasury bond yield. The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9 BP upside down from the current 1-year treasury bond yield.Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.
Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.Market News: Brian Quintenz has become the top contender for the chairmanship of the Commodity Futures Trading Commission (CFTC).